TargTex is developing a highly-targeted therapy for the treatment of Glioblastoma Multiforme.

Based on an artificial intelligence algorithm, TargTex determined a novel correlation between a small molecule and a target that is overexpressed in Glioblastoma Multiforme. TargTex is developing a product as an adjunct to surgery taking advantage of this selective therapy towards an unexplored target.

Our Mission

TargTex is developing a concerted approach, aligning scientists, physicians and patients to advance an innovative therapy to treat a daunting disease, giving a chance to Glioblastoma Multiforme patients to live instead of surviving.

Latest News

News / Events / Awards / Publications